PEDF: anti-angiogenic guardian of ocular function

Publisher： Elsevier

ISSN： 1471-4914

Source： Trends in Molecular Medicine, Vol.8, Iss.7, 2002-07, pp. : 330-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PEDF in Angiogenic Eye Diseases

Current Molecular Medicine, Vol. 10, Iss. 3, 2010-04 ,pp. : 267-278

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Cancer Therapy Updates

Current Molecular Medicine, Vol. 9, Iss. 8, 2009-11 ,pp. : 954-966

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Atherothrombogenic Properties of PEDF

Current Molecular Medicine, Vol. 10, Iss. 3, 2010-04 ,pp. : 284-291

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Function Relationships of PEDF

Current Molecular Medicine, Vol. 10, Iss. 3, 2010-04 ,pp. : 302-311

Bentham Science Publishers

Access to resources Recommend Favorite

Promises and pitfalls of anti-angiogenic therapy in clinical trials

By McCarty M.F. Liu W. Fan F. Parikh A. Reimuth N. Stoeltzing O. Ellis L.M.

Trends in Molecular Medicine, Vol. 9, Iss. 2, 2003-02 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite